About US
Contact us
-
Merck's Keytruda tops chemo in first-line lung cancer trialMerck & Co. just scored a point in its immuno-oncology rivalry against Bristol-Myers Squibb. The PD-1 checkpoint inhibitor Keytruda hit its goals in a new trial in previously untreated non-small c2016/6/28
-
AstraZeneca, Teva settle Byetta patent suit; generics on their wayImmediately following AstraZeneca’s big FluMist setback Thursday, the British pharma has entered into an agreement with Teva that will likely lead to sales losses for another product, Byetta. AstraZe2016/6/27
-
Pharma accuses payers of using cash to sway U.S. cost watchdogDrugmakers haven’t much cared for a Boston-based nonprofit’s cost-effectiveness assessments of their drugs--especially considering that the group usually turns out “too pricey” verdicts. And now, they2016/6/27
-
New report says leukaemia has largest active development pipelineLeukaemia has the largest pipeline in active development from the three major indications within haematological cancer, also comprising lymphoma and myeloma, according to a new report by GBI Research.2016/6/24
-
Orion and Asahi Kasei reach agreement for pain management assetsFinnish pharmaceutical and diagnostics company Orion has entered into a global strategic collaboration agreement with Japan-based Asahi Kasei Pharma to discover, develop and commercialise assets in pa2016/6/24
-
AbbVie, Eisai and EA Pharma receive additional approval for new Humira dosing regimenAbbVie GK, the Japanese subsidiary of AbbVie, Eisai and its subsidiary EA Pharma have received the additional approval for a new dosing regimen of Humira Pre-filled Syringe 40mg / 0.8mL for Subcutaneo2016/6/23
-
UK NICE grants Technology Appraisal Guidance for Sanofi’s Praluent (alirocumab)The UK National Institute for Health and Care Excellence (NICE) has granted Technology Appraisal Guidance (TAG) for French pharmaceutical company Sanofi's latest cholesterol-lowering treatment, Pralue2016/6/23
-
US NHRC commences clinical trial of norovirus vaccine at RTCThe US Naval Health Research Centre (NHRC) has launched a clinical trial at Recruit Training Command (RTC) in a bid to assess the effectiveness of the first norovirus vaccine in reducing outbreaks of2016/6/22
-
US NHRC commences clinical trial of norovirus vaccine at RTCThe US Naval Health Research Centre (NHRC) has launched a clinical trial at Recruit Training Command (RTC) in a bid to assess the effectiveness of the first norovirus vaccine in reducing outbreaks of2016/6/22
-
Modality Solutions' Partner Bioconvergence® Rebrands as Singota™ SolutionsLife-sciences contract service provider BioConvergence has rebranded as Singota Solutions to respond to its client's needs. As part of the transition, the company expanded its services in line of CEO2016/6/21